Skip to content

Takeda Pharmaceutical Co Ltd ADR Price, Chart & Factor Analysis

Free Data & Analytics Access

Latest earnings: October 29, 2026 results vs estimates

Takeda Pharmaceutical Co Ltd ADR · E.TAK.NYSE · United States
Use symbol E.TAK.NYSE in our API & Excel add-in to retrieve this data ↓
20.01
(-0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 19.41%

Takeda Pharmaceutical Co Ltd ADR Forecast

Takeda Pharmaceutical Co Ltd ADR short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 19.4% a year, a typical one-standard-deviation range is 19.46–20.56 over a week, 18.89–21.13 over a month and 16.13–23.89 over a year. (Signals as of 1 Nov 2026.)

Takeda Pharmaceutical Co Ltd ADR Price Chart

MacroFinance.ai

Takeda Pharmaceutical Co Ltd ADR Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Takeda Pharmaceutical Co Ltd ADR
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Takeda Pharmaceutical Co Ltd ADR
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Takeda Pharmaceutical Co Ltd ADR
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Takeda Pharmaceutical Co Ltd ADR, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Takeda Pharmaceutical Co Ltd ADR

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Takeda Pharmaceutical Co Ltd ADR Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Takeda Pharmaceutical Co Ltd ADR; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Takeda Pharmaceutical Co Ltd ADR’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Takeda Pharmaceutical Co Ltd ADR behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Takeda Pharmaceutical Co Ltd ADR (United States)

Takeda Pharmaceutical Co Ltd ADR is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Takeda Pharmaceutical Co Ltd ADR?
Takeda Pharmaceutical Co Ltd ADR is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Takeda Pharmaceutical Co Ltd ADR price?
The latest close is 20.01 (1 Nov 2026), -0.01% on the day. The price at the top of the page refreshes during the trading day.
Is Takeda Pharmaceutical Co Ltd ADR in an uptrend?
As of 1 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Takeda Pharmaceutical Co Ltd ADR?
20-day realised volatility is 19.4% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 5.6% over a month and 2.7% over a week.
What factors affect Takeda Pharmaceutical Co Ltd ADR?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Takeda Pharmaceutical Co Ltd ADR, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Takeda Pharmaceutical Co Ltd ADR?
58 backtested tactical asset allocation strategies trade Takeda Pharmaceutical Co Ltd ADR through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Takeda Pharmaceutical Co Ltd ADR returns analysed?
The Statistical Distribution of Returns section shows the distribution of Takeda Pharmaceutical Co Ltd ADR daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Takeda Pharmaceutical Co Ltd ADR historical data?
In the Free historical data section of this page: the last 10 years of Takeda Pharmaceutical Co Ltd ADR daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Takeda Pharmaceutical Co Ltd ADR historical data (last 10 years)

Browse or instantly download the last 10 years of Takeda Pharmaceutical Co Ltd ADR daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.TAK.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2021.77
2026-11-1921.41
2026-11-1821.27
2026-11-1721.64
2026-11-1621.59
2026-11-1321.43
2026-11-1221.12
2026-11-1120.84
2026-11-1020.93
2026-11-0921.09
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enantone, Ninlaro, Iclusig, FRUZAQLA, Alunbrig, vyvanse/elvanse, Trintellix, and QDENGA brands. It has licensing and collaboration for the development and commercialization of products with Arrowhead Pharmaceuticals, Cour Pharmaceuticals, Engitix, Halozyme, Mirum Pharmaceuticals, Ucsd/Fortis Advisors, Zedira/Dr. Falk Pharma, Ac Immune, Acurastem, Anima Biotech, Biomarin, Denali Therapeutics, Luxna Biotech, Neurocrine Biosciences, Peptidream, Abbvie, Adimab, Ascentage Pharma, Crescendo Biologics, Exelixis, F-Star, Gsk, Heidelberg Pharma, Innovent Biologics, Keros Therapeutics, Kumquat Biosciences, Protagonist Therapeutics, Halozyme, Kamada, Johnson & Johnson/Momenta Pharmaceuticals, Previpharma, Novavax, Bridgene Biosciences, Charles River Laboratories, Iambic Therapeutics, Ipsen, Km Biologics, Massachusetts Institute Of Technology, and Nabla Bio. The company operates in Japan, the United States. Europe, Canada, Latin America, China, Asia, Russia/Commonwealth of Independent States, the Middle East, Oceania, and Africa. The company was founded in 1781 and is headquartered in Chuo, Japan.